The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

Press releases published on May 26, 2026

Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Global Entertainment and Events Company Partners with Aeries to Scale Enterprise Technology Operations
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules
Dynacor Group Announces June 2026 Dividend
Groupe Dynacor déclare son dividende pour juin 2026
Plato Gold Reports on First Quarter 2026 Results, Adopts Semi-Annual Financial Reporting
NIOB to Feature Seigneurie Drill Core at THE Mining Investment Event
NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study
Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Azimut Drills 46.41 g/t Au over 3.50 m, incl. 155 g/t Au over 1.0 m on Rosa Zone, Wabamisk Property, James Bay, Québec
Azimut fore 46,41 g/t Au sur 3,50 m incluant 155 g/t Au sur 1,0 m sur la Zone Rosa, Propriété Wabamisk, région de la Baie-James, Québec
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026
Emira 420 Sport: the lightest and most powerful Emira yet
Bitget lists Solstice Finance (SLX) for Spot Trading

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Latin American Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.